FDA chief’s long-promised opioid review faces skepticism
WASHINGTON, D.C. — As U.S. opioid deaths mounted in 2016, the incoming head of the Food and Drug Administration promised a “sweeping review” of prescription painkillers in hopes of reversing the worst overdose epidemic in […]